Randomised controlled trials, reported until June 2022, will be retrieved from electronic databases such as Medline, EMBASE and Cochrane Library. We will compare the effects of herbal medicine in patients presenting with PONV after LS with those of Western medicine, placebo and no treatment. If sufficient studies are identified, we will evaluate the combined effects of herbal and Western medicine. The incidence of nausea and vomiting will be considered the primary outcome. Secondary outcomes will include the intensity of complaints, quality of life and incidence of adverse events. Two independent reviewers will collect data based on the Preferred Reporting Items for Systematic Review and Meta-Analyses statement, evaluate the quality of each study using the Cochrane risk-of-bias tool and synthesise the results via meta-analysis, if possible.
Ethical approval is not required for this review. The results of this study will be disseminated to peer-reviewed journals and posters.
CRD42022345749.
方法:随机对照试验,报告到2022年6月,将从Medline等电子数据库中检索,EMBASE和Cochrane图书馆。我们将比较LS后出现PONV的患者与西药的效果,安慰剂和不治疗。如果有足够的研究,我们将评估中草药和西药的联合作用。恶心和呕吐的发生率将被认为是主要结果。次要结果将包括投诉的强度,生活质量和不良事件发生率。两名独立审核员将根据系统审查和荟萃分析声明的首选报告项目收集数据,使用Cochrane偏差风险工具评估每项研究的质量,并通过荟萃分析综合结果,如果可能的话。
背景:本审查不需要道德批准。这项研究的结果将传播给同行评审的期刊和海报。
■CRD42022345749。